Alkem Laboratories Limited
ALKEM
Classifica tra le azioni
#2796
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Prezzo delle azioni
$52.07
Capitalizzazione di mercato
$6.23B
Variazione (1 giorno)
-5.66%
Variazione (1 anno)
-17.38%
Paese
IN
Scambia Alkem Laboratories Limited (ALKEM)
Categoria
Healthcare
Ricavi di Alkem Laboratories Limited (ALKEM)
Ricavi nel Jun 2026 TTM: $1.66B
Secondo gli ultimi rapporti finanziari di Alkem Laboratories Limited, i ricavi attuali dell'azienda (TTM) sono pari a $1.66B. Nel 2024, l'azienda ha registrato ricavi di $1.51B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $1.41B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Alkem Laboratories Limited da 2010 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $1.66B | 9.80% |
| 2025 | $1.52B | 0.58% |
| 2024 | $1.51B | 6.78% |
| 2023 | $1.41B | 0.75% |
| 2022 | $1.40B | 16.24% |
| 2021 | $1.21B | 10.84% |
| 2020 | $1.09B | 3.92% |
| 2019 | $1.05B | 7.90% |
| 2018 | $969.78M | 11.98% |
| 2017 | $866.05M | 17.92% |
| 2016 | $734.41M | 23.43% |
| 2015 | $595.01M | 15.94% |
| 2014 | $513.19M | 20.29% |
| 2013 | $426.63M | 10.75% |
| 2012 | $385.23M | 3.89% |
| 2011 | $370.79M | 23.92% |
| 2010 | $299.23M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
